Isolation and Characterization of Engineered Nucleoside Deoxyribosyltransferase with Enhanced Activity Toward 2'-Fluoro-2'-Deoxynucleoside |
Yoo, Yeon-Jin
(Department of Biological Sciences and Bioengineering, Inha University)
Choi, Kang-Hyun (Department of Biological Sciences and Bioengineering, Inha University) Kim, Byoung-Kyun (Division of Bioprocess Discovery, ST Pharm) Choi, Si-Sun (Department of Biological Sciences and Bioengineering, Inha University) Kim, Eung-Soo (Department of Biological Sciences and Bioengineering, Inha University) |
1 | Crooke ST, Baker BF, Crooke RM, Liang, X-H. 2021. Antisense technology: an overview and prospectus. Nat. Rev. Drug. Discov. 20: 427-453. DOI |
2 | Dhuri K, Bechtold C, Quijano E, Pham H, Gupta A, Vikram A, et al. 2020. Antisense oligonucleotides: an emerging area in drug discovery and development. J. Clin. Med. 9: 2004. DOI |
3 | Xiong H, Veedu RN, Diermeier SD. 2021. Recent advances in oligonucleotide therapeutics in oncology. Int. J. Mol. Sci. 22: 3295. DOI |
4 | Munch-Petersen. 1983. Metabolism of nucleotides, nucleosides and nucleobases in microorganisms. Academic Press Inc. 203-258. |
5 | Cadwell RC, Joyce GF. 1992. Randomization of genes by PCR mutagenesis. PCR Methods Appl. 2: 28-33. DOI |
6 | Danzin C, Cardinaud R. 1976. Deoxyribosyl transfer catalysis with trans-N-deoxyribosylase. Eur. J. Biochem. 62: 365-72. DOI |
7 | Roush AH, Betz RF. 1958. Purification and properties of trans-N-deoxyribosylase. J. Biol. Chem. 233: 261-266. DOI |
8 | Cardinaud R, Holguin J. 1979. Nucleoside deoxyribosyltransferase-II from Lactobacillus helveticus substrate specificity studied. Pyrimidine bases as acceptors. Biochim. Biophys. Acta 568: 339-347. DOI |
9 | Danzin C, Cardinaud R. 1974. Deoxyribosyl transfer catalysis with trans-N-deoxyribosylase. Eur. J. Biochem. 48: 255-262. DOI |
10 | Lysik MA, Wu-Pong S. 2003. Innovations in oligonucleotide drug delivery. J. Pharm. Sci. 92: 1559-1573. DOI |
11 | Liu P, Sharon A, Chu CK. 2008. Fluorinated nucleosides: synthesis and biological implication. J. Fluor. Chem. 129: 743-766. DOI |
12 | Wilson DS, Keefe AD. 2001. Random mutagenesis by PCR. Curr. Protoc. Mol. Biol. Chapter 8: unit 8.3. |
13 | Wilds CJ, Damha MJ. 2000. 2'-Deoxy-2'-fluoro-beta-D-arabinonucleosides and oligonucleotides (2'F-ANA): synthesis and physicochemical studies. Nucleic. Acids Res. 28: 3625-3635. DOI |
14 | Chan JHP, Lim S, Wong WSF. 2006. Antisense oligonucleotides: from design to therapeutic application. Clin. Exp. Pharmacol. Physiol. 33: 533-540. DOI |
15 | Ochoa S, Milam VT. 2020. Modified nucleic acids: expanding the capabilities of functional oligonucleotides. Molecules 25: 4659. DOI |
16 | McKenzie LK, El-Khoury R, Thorpe JD, Damha MJ, Hollenstein M. 2021. Recent progress in non-native nucleic acid modifications. Chem. Soc. Rev. 50: 5126-5164. DOI |
17 | Manoharan M. 1999. 2'-Carbohydrate modifications in antisense oligonucleotide therapy: importance of conformation, configuration and conjugation. Biochim. Biophys. Acta. 1489: 117-130. DOI |
![]() |